Pharmaids Pharmaceuticals Board Approves Q1 FY27 Unaudited Results

Pharmaids Pharmaceuticals Ltd announced the outcome of its Board meeting held on August 12, 2026. The Board approved the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. A Limited Review Report from statutory auditors M/s PPKG & Co was also enclosed. Additionally, the Board considered and approved the Notice of the 37th Annual General Meeting (AGM), which will be held via Video Conferencing (VC) or Other Audio-Visual Means (OAVM). The meeting commenced at 4:57 PM and concluded at 6:15 PM.